XML 31 R24.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Business Combinations (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
Mapi Group [Member] |
Schedule of summary of recognized identified assets acquired and liabilities assumed | The table following summarizes the Company’s provisional estimates of the fair values of the assets acquired and liabilities assumed:
| July 27, 2017 |
| (in thousands) |
Cash | $ | 19,649 |
Property, plant and equipment | 4,872 |
Goodwill* | 129,344 |
Intangible assets** | 32,330 |
Accounts receivable | 15,874 |
Unbilled revenue | 6,984 |
Prepayments and other current assets | 2,587 |
Other receivables | 1,430 |
Income taxes receivable | 4,262 |
Accounts payable | (2,994 | )
Payments on account | (31,445 | )
Other liabilities | (24,952 | )
Non-current other liabilities | (1,061 | )
Non-current deferred tax liability | (11,104 | )
Net assets acquired | $ | 145,776 |
Cash outflows | $ | 144,131 |
Working capital adjustment | 1,645 |
Total consideration | $ | 145,776 |
*Goodwill represents the acquisition of an established workforce with experience in late phase commercialization, analytics, real world evidence generation and strategic regulatory services in clinical trial services for biologics, drugs and devices. Goodwill related to the business acquired is not tax deductible. **The Company has made an initial estimate of separate intangible assets acquired of $32.3 million, being customer relationships and order book assets. This assessment is under review and will be finalized within 12 months of the date of acquisition.
Clinical Research Management Inc. |
Schedule of summary of recognized identified assets acquired and liabilities assumed | The acquisition of ClinicalRM has been accounted for as a business combination in accordance with FASB ASC 805 Business Combinations. The table following summarizes the fair values of the assets acquired and liabilities assumed:
| September 15, 2016 |
| (in thousands) |
Cash | $ | 3,168 |
Property, plant and equipment | 939 |
Goodwill* | 35,969 |
Customer lists | 4,012 |
Order backlog | 1,668 |
Brand | 1,409 |
Accounts receivable | 11,431 |
Unbilled revenue | 3,868 |
Prepayments and other current assets | 1,673 |
Accounts payable | (165 | )
Other liabilities | (5,569 | )
Non-current other liabilities | (7 | )
Net assets acquired | $ | 58,396 |
Total consideration | $ | 58,396 |
*Goodwill represents the acquisition of an established workforce with experience in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. Goodwill related to the US portion of the business acquired is tax deductible.

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iclr_MapiGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iclr_ClinicalResearchManagementIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |